Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed May 15, 2017 · 10-Q · 45 days after period end · 0001564590-17-010905
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$205.00K | -$242.00K | -$4.52M | -$8.64M |
| EPS Diluted | -$96.56 | -$11.40 | $0.20 | -$0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 15, 2017 · 45 d after period end
